Tumor cell-derived ISG15 promotes fibroblast recruitment in oral squamous cell carcinoma via CD11a-dependent glycolytic reprogramming

Cancer-associated fibroblast (CAF) recruitment and activation within the tumor microenvironment (TME) are increasingly acknowledged as drivers of oral squamous cell carcinoma (OSCC) tumor growth and metastasis. Therefore, the mechanisms underlying tumor cell and fibroblast crosstalk warrant further...

Full description

Saved in:
Bibliographic Details
Published inOncogenesis (New York, NY) Vol. 14; no. 1; pp. 6 - 13
Main Authors Wang, Ssu-Han, Chen, Yu-Lin, Huang, Shih-Han, Fu, Yu-Ke, Lin, Su-Fang, Jiang, Shih Sheng, Liu, Shu-Chen, Hsiao, Jenn-Ren, Chang, Jang-Yang, Chen, Ya-Wen
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 11.03.2025
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cancer-associated fibroblast (CAF) recruitment and activation within the tumor microenvironment (TME) are increasingly acknowledged as drivers of oral squamous cell carcinoma (OSCC) tumor growth and metastasis. Therefore, the mechanisms underlying tumor cell and fibroblast crosstalk warrant further investigation. We discovered that ectopic interferon-stimulated gene 15 (ISG15) expression, which is a promising and novel oncoprotein biomarker elevated in a variety of cancers, enhanced OSCC growth and elevated collagen and α-smooth muscle actin (α-SMA) expression in ISG15-expressing tumors. Analysis of immunohistochemistry revealed high ISG15 expression in human oral tissues correlated with high expression of α-SMA and fibroblast activation protein (FAP). Fibroblast migration and recruitment by ISG15-expressing OSCC cells were confirmed by in vitro and in vivo experiments. Exogenous ISG15 induced fibroblast migration, morphological changes, and vimentin expression. Enrichment of glycolysis pathway genes, as well as increased glycolysis-related gene expression, glucose uptake, and lactate production were observed in ISG15-treated fibroblasts. Lactate release and fibroblast migration were blocked by a competitive inhibitor of glucose metabolism. Furthermore, the knockdown of integrin αL (ITGAL)/CD11a, a subunit of ISG15 receptor lymphocyte functional-associated antigen-1 (LFA-1), in immortalized fibroblasts diminished extracellular ISG15-mediated glycolysis and migration. Our findings suggest that ISG15 derived from OSCC cells interacts with fibroblasts through the LFA-1 receptor, leading to glycolytic reprogramming and promotion of fibroblast migration into the TME.
AbstractList Cancer-associated fibroblast (CAF) recruitment and activation within the tumor microenvironment (TME) are increasingly acknowledged as drivers of oral squamous cell carcinoma (OSCC) tumor growth and metastasis. Therefore, the mechanisms underlying tumor cell and fibroblast crosstalk warrant further investigation. We discovered that ectopic interferon-stimulated gene 15 (ISG15) expression, which is a promising and novel oncoprotein biomarker elevated in a variety of cancers, enhanced OSCC growth and elevated collagen and α-smooth muscle actin (α-SMA) expression in ISG15-expressing tumors. Analysis of immunohistochemistry revealed high ISG15 expression in human oral tissues correlated with high expression of α-SMA and fibroblast activation protein (FAP). Fibroblast migration and recruitment by ISG15-expressing OSCC cells were confirmed by in vitro and in vivo experiments. Exogenous ISG15 induced fibroblast migration, morphological changes, and vimentin expression. Enrichment of glycolysis pathway genes, as well as increased glycolysis-related gene expression, glucose uptake, and lactate production were observed in ISG15-treated fibroblasts. Lactate release and fibroblast migration were blocked by a competitive inhibitor of glucose metabolism. Furthermore, the knockdown of integrin αL (ITGAL)/CD11a, a subunit of ISG15 receptor lymphocyte functional-associated antigen-1 (LFA-1), in immortalized fibroblasts diminished extracellular ISG15-mediated glycolysis and migration. Our findings suggest that ISG15 derived from OSCC cells interacts with fibroblasts through the LFA-1 receptor, leading to glycolytic reprogramming and promotion of fibroblast migration into the TME.
Abstract Cancer-associated fibroblast (CAF) recruitment and activation within the tumor microenvironment (TME) are increasingly acknowledged as drivers of oral squamous cell carcinoma (OSCC) tumor growth and metastasis. Therefore, the mechanisms underlying tumor cell and fibroblast crosstalk warrant further investigation. We discovered that ectopic interferon-stimulated gene 15 (ISG15) expression, which is a promising and novel oncoprotein biomarker elevated in a variety of cancers, enhanced OSCC growth and elevated collagen and α-smooth muscle actin (α-SMA) expression in ISG15-expressing tumors. Analysis of immunohistochemistry revealed high ISG15 expression in human oral tissues correlated with high expression of α-SMA and fibroblast activation protein (FAP). Fibroblast migration and recruitment by ISG15-expressing OSCC cells were confirmed by in vitro and in vivo experiments. Exogenous ISG15 induced fibroblast migration, morphological changes, and vimentin expression. Enrichment of glycolysis pathway genes, as well as increased glycolysis-related gene expression, glucose uptake, and lactate production were observed in ISG15-treated fibroblasts. Lactate release and fibroblast migration were blocked by a competitive inhibitor of glucose metabolism. Furthermore, the knockdown of integrin αL (ITGAL)/CD11a, a subunit of ISG15 receptor lymphocyte functional-associated antigen-1 (LFA-1), in immortalized fibroblasts diminished extracellular ISG15-mediated glycolysis and migration. Our findings suggest that ISG15 derived from OSCC cells interacts with fibroblasts through the LFA-1 receptor, leading to glycolytic reprogramming and promotion of fibroblast migration into the TME.
Cancer-associated fibroblast (CAF) recruitment and activation within the tumor microenvironment (TME) are increasingly acknowledged as drivers of oral squamous cell carcinoma (OSCC) tumor growth and metastasis. Therefore, the mechanisms underlying tumor cell and fibroblast crosstalk warrant further investigation. We discovered that ectopic interferon-stimulated gene 15 (ISG15) expression, which is a promising and novel oncoprotein biomarker elevated in a variety of cancers, enhanced OSCC growth and elevated collagen and α-smooth muscle actin (α-SMA) expression in ISG15-expressing tumors. Analysis of immunohistochemistry revealed high ISG15 expression in human oral tissues correlated with high expression of α-SMA and fibroblast activation protein (FAP). Fibroblast migration and recruitment by ISG15-expressing OSCC cells were confirmed by in vitro and in vivo experiments. Exogenous ISG15 induced fibroblast migration, morphological changes, and vimentin expression. Enrichment of glycolysis pathway genes, as well as increased glycolysis-related gene expression, glucose uptake, and lactate production were observed in ISG15-treated fibroblasts. Lactate release and fibroblast migration were blocked by a competitive inhibitor of glucose metabolism. Furthermore, the knockdown of integrin αL (ITGAL)/CD11a, a subunit of ISG15 receptor lymphocyte functional-associated antigen-1 (LFA-1), in immortalized fibroblasts diminished extracellular ISG15-mediated glycolysis and migration. Our findings suggest that ISG15 derived from OSCC cells interacts with fibroblasts through the LFA-1 receptor, leading to glycolytic reprogramming and promotion of fibroblast migration into the TME.Cancer-associated fibroblast (CAF) recruitment and activation within the tumor microenvironment (TME) are increasingly acknowledged as drivers of oral squamous cell carcinoma (OSCC) tumor growth and metastasis. Therefore, the mechanisms underlying tumor cell and fibroblast crosstalk warrant further investigation. We discovered that ectopic interferon-stimulated gene 15 (ISG15) expression, which is a promising and novel oncoprotein biomarker elevated in a variety of cancers, enhanced OSCC growth and elevated collagen and α-smooth muscle actin (α-SMA) expression in ISG15-expressing tumors. Analysis of immunohistochemistry revealed high ISG15 expression in human oral tissues correlated with high expression of α-SMA and fibroblast activation protein (FAP). Fibroblast migration and recruitment by ISG15-expressing OSCC cells were confirmed by in vitro and in vivo experiments. Exogenous ISG15 induced fibroblast migration, morphological changes, and vimentin expression. Enrichment of glycolysis pathway genes, as well as increased glycolysis-related gene expression, glucose uptake, and lactate production were observed in ISG15-treated fibroblasts. Lactate release and fibroblast migration were blocked by a competitive inhibitor of glucose metabolism. Furthermore, the knockdown of integrin αL (ITGAL)/CD11a, a subunit of ISG15 receptor lymphocyte functional-associated antigen-1 (LFA-1), in immortalized fibroblasts diminished extracellular ISG15-mediated glycolysis and migration. Our findings suggest that ISG15 derived from OSCC cells interacts with fibroblasts through the LFA-1 receptor, leading to glycolytic reprogramming and promotion of fibroblast migration into the TME.
ArticleNumber 6
Author Fu, Yu-Ke
Chen, Ya-Wen
Lin, Su-Fang
Liu, Shu-Chen
Huang, Shih-Han
Hsiao, Jenn-Ren
Chen, Yu-Lin
Jiang, Shih Sheng
Chang, Jang-Yang
Wang, Ssu-Han
Author_xml – sequence: 1
  givenname: Ssu-Han
  surname: Wang
  fullname: Wang, Ssu-Han
  organization: National Institute of Cancer Research, National Health Research Institutes
– sequence: 2
  givenname: Yu-Lin
  surname: Chen
  fullname: Chen, Yu-Lin
  organization: National Institute of Cancer Research, National Health Research Institutes
– sequence: 3
  givenname: Shih-Han
  surname: Huang
  fullname: Huang, Shih-Han
  organization: National Institute of Cancer Research, National Health Research Institutes
– sequence: 4
  givenname: Yu-Ke
  surname: Fu
  fullname: Fu, Yu-Ke
  organization: National Institute of Cancer Research, National Health Research Institutes
– sequence: 5
  givenname: Su-Fang
  orcidid: 0000-0001-8706-2439
  surname: Lin
  fullname: Lin, Su-Fang
  organization: National Institute of Cancer Research, National Health Research Institutes
– sequence: 6
  givenname: Shih Sheng
  surname: Jiang
  fullname: Jiang, Shih Sheng
  organization: National Institute of Cancer Research, National Health Research Institutes
– sequence: 7
  givenname: Shu-Chen
  surname: Liu
  fullname: Liu, Shu-Chen
  organization: Department of Biomedical Sciences and Engineering, National Central University
– sequence: 8
  givenname: Jenn-Ren
  surname: Hsiao
  fullname: Hsiao, Jenn-Ren
  organization: Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University
– sequence: 9
  givenname: Jang-Yang
  surname: Chang
  fullname: Chang, Jang-Yang
  organization: Taipei Cancer Center, Taipei Medical University Hospital, TMU Research Center of Cancer Translational Medicine, College of Medicine, Taipei Medical University, Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes
– sequence: 10
  givenname: Ya-Wen
  orcidid: 0000-0002-6080-8859
  surname: Chen
  fullname: Chen, Ya-Wen
  email: ywc@nhri.edu.tw
  organization: National Institute of Cancer Research, National Health Research Institutes, Ph.D. Program for Aging, Graduate Institute of Basic Medical Science, China Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40069143$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1u1DAUhSNUREvpC7BAltiwCfg_yQqhAcpIlVhQ1tb1T4KrxJ7ayUjzAH1vPDOltCzIxpF97nevj8_L6iTE4KrqNcHvCWbth8wJa7saU1FjLHhX02fVGSWiqTtM-cmj_9PqIucbXD4hiRTiRXXKMZYd4eysurteppiQceNYW5f81lm0_nFJBNqkOMXZZdR7naIeIc8oOZMWP08uzMgHFBOMKN8uMMUlHxjIQDI-xAnQ1gNafSYECnfjgt3XDOPOxHE3e1NQpcGQYJp8GF5Vz3sYs7u4X8-rn1-_XK--1VffL9erT1e14R2fay27HvdE4hYa2jZMkL7VmlPZA4DQRAKVpuManLRNzx00hlGt26ahHe2pZufV-si1EW7UJvkJ0k5F8OqwEdOgIJXpRqfAWeJ62WvTCN4KC1YDZpJhw6y1jBfWxyNrs-jJWVPuV-x4An16EvwvNcStIqTtGspEIby7J6R4u7g8q8nnvYsQXDFUMdLI0ghLVqRv_5HexCWF4tVBRYhoKSmqN49Hepjlz3MXAT0KTIo5J9c_SAhW-1ipY6xUiZU6xErRUsSORbmIw-DS397_qfoN_XvR7A
Cites_doi 10.4161/cc.8.23.10238
10.1038/s41388-019-0731-8
10.1038/s41587-020-0546-8
10.7150/thno.47901
10.1038/ncomms10305
10.3390/cancers12010061
10.1128/MCB.22.14.5157-5172.2002
10.1158/0008-5472.CAN-12-4150
10.3390/cancers13061230
10.1016/j.cell.2017.10.044
10.1186/s13046-022-02300-w
10.1016/j.canlet.2020.03.004
10.1016/j.ccr.2009.12.041
10.1093/carcin/bgt035
10.1002/ijc.32613
10.1016/j.cytogfr.2012.07.003
10.18632/oncotarget.18175
10.1016/j.canlet.2014.07.028
10.1002/ijc.32193
10.1371/journal.pone.0043593
10.3389/froh.2021.686337
10.1038/ng.3225
10.1016/j.ccell.2023.02.015
10.1016/j.molcel.2017.10.003
10.1111/j.1365-2559.2007.02873.x
10.1158/0008-5472.CAN-12-1949
10.1186/s13046-022-02456-5
10.1186/s12935-020-01255-2
10.1128/MCB.20.4.1436-1447.2000
10.2147/OTT.S294725
10.1186/bcr2615
10.1007/s00418-008-0530-8
10.3390/biology12071002
10.1016/j.oraloncology.2007.08.012
10.3390/cancers12071718
10.1038/s41573-018-0004-1
10.1016/j.bbrc.2012.09.115
10.1177/1533033820971670
10.1038/nrc1877
10.3389/fonc.2019.00356
10.1002/path.4173
10.1186/s40659-017-0108-9
10.1172/JCI144888
10.1186/s40164-024-00531-5
10.18632/oncotarget.3372
10.1038/nrc.2016.73
10.1158/1078-0432.CCR-17-1776
10.3389/fimmu.2020.594775
10.1016/j.ccell.2023.02.016
10.1152/physrev.00048.2019
10.1016/j.cytogfr.2006.10.001
10.1089/jir.2016.0103
10.1158/0008-5472.CAN-14-1354
10.1016/j.ajpath.2021.02.010
10.18632/oncotarget.5995
10.1038/s41388-022-02540-2
10.1016/S0021-9258(18)68561-8
ContentType Journal Article
Copyright The Author(s) 2025
2025. The Author(s).
Copyright Nature Publishing Group Dec 2025
The Author(s) 2025 2025
Copyright_xml – notice: The Author(s) 2025
– notice: 2025. The Author(s).
– notice: Copyright Nature Publishing Group Dec 2025
– notice: The Author(s) 2025 2025
DBID C6C
AAYXX
CITATION
NPM
3V.
7X7
7XB
88A
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M2P
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
Q9U
7X8
5PM
DOA
DOI 10.1038/s41389-025-00549-2
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database

MEDLINE - Academic
PubMed

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2157-9024
EndPage 13
ExternalDocumentID oai_doaj_org_article_aed1ef6fbc75485dadba03630c3ddd34
PMC11897235
40069143
10_1038_s41389_025_00549_2
Genre Journal Article
GrantInformation_xml – fundername: Ministry of Health and Welfare (Ministry of Health and Welfare, Taiwan)
  grantid: MOHW 113-TDU-B-222-134012
  funderid: https://doi.org/10.13039/100008903
– fundername: National Health Research Institutes (NHRI)
  grantid: NHRI CA-113-PP-04
  funderid: https://doi.org/10.13039/501100004737
– fundername: National Science and Technology Council, NSTC 112-2314-B-400-005
– fundername: Ministry of Health and Welfare (Ministry of Health and Welfare, Taiwan)
  grantid: MOHW 113-TDU-B-222-134012
– fundername: National Health Research Institutes (NHRI)
  grantid: NHRI CA-113-PP-04
GroupedDBID 0R~
53G
5VS
7X7
88I
8FE
8FH
8FI
8FJ
AAJSJ
ABDBF
ABUWG
ACGFS
ACUHS
ADBBV
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBLON
EBS
FYUFA
GNUQQ
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
KQ8
LK8
M2P
M7P
M~E
NAO
OK1
PGMZT
PHGZT
PIMPY
PQQKQ
PROAC
RNT
RNTTT
RPM
UKHRP
AASML
AAYXX
CITATION
PHGZM
SNYQT
NPM
3V.
7XB
88A
8FK
K9.
PKEHL
PQEST
PQGLB
PQUKI
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c494t-b69f0f1608a7287351f8bb426faaa5b16a26c94bae6d7f4ea7c32bb877292f2b3
IEDL.DBID DOA
ISSN 2157-9024
IngestDate Wed Aug 27 01:06:09 EDT 2025
Thu Aug 21 18:34:32 EDT 2025
Fri Jul 11 04:48:32 EDT 2025
Fri Jul 18 05:21:03 EDT 2025
Sat Mar 15 01:20:51 EDT 2025
Tue Jul 01 05:17:03 EDT 2025
Wed Mar 12 01:32:00 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c494t-b69f0f1608a7287351f8bb426faaa5b16a26c94bae6d7f4ea7c32bb877292f2b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-8706-2439
0000-0002-6080-8859
OpenAccessLink https://doaj.org/article/aed1ef6fbc75485dadba03630c3ddd34
PMID 40069143
PQID 3176115821
PQPubID 2041913
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_aed1ef6fbc75485dadba03630c3ddd34
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11897235
proquest_miscellaneous_3176343063
proquest_journals_3176115821
pubmed_primary_40069143
crossref_primary_10_1038_s41389_025_00549_2
springer_journals_10_1038_s41389_025_00549_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-03-11
PublicationDateYYYYMMDD 2025-03-11
PublicationDate_xml – month: 03
  year: 2025
  text: 2025-03-11
  day: 11
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: United States
– name: New York
PublicationTitle Oncogenesis (New York, NY)
PublicationTitleAbbrev Oncogenesis
PublicationTitleAlternate Oncogenesis
PublicationYear 2025
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References VJ Tuominen (549_CR58) 2010; 12
X Wu (549_CR28) 2017; 50
R Kalluri (549_CR32) 2006; 6
M Nurmik (549_CR29) 2020; 146
R Kalluri (549_CR4) 2016; 16
PJ Lee (549_CR56) 2022; 41
Y Hassona (549_CR14) 2013; 34
C Zhang (549_CR37) 2020; 20
JG Rheinwald (549_CR55) 2002; 22
AM Richardson (549_CR44) 2018; 24
ZS Lin (549_CR57) 2012; 7
PF Dos Santos (549_CR22) 2017; 37
S Pavlides (549_CR17) 2009; 8
MJ Goldman (549_CR26) 2020; 38
CD Swaim (549_CR25) 2017; 68
KE de Visser (549_CR1) 2023; 41
N Fujii (549_CR7) 2012; 41
LF Gao (549_CR43) 2022; 41
AJ Daly (549_CR9) 2008; 44
A De Vincenzo (549_CR12) 2019; 145
549_CR30
X Zhang (549_CR51) 2020; 10
B Sainz Jr (549_CR24) 2014; 74
J Burks (549_CR21) 2015; 6
549_CR35
IA Sevostyanova (549_CR39) 2012; 427
N Erez (549_CR13) 2010; 17
X Wu (549_CR42) 2020; 478
S Wen (549_CR40) 2021; 14
A Avgustinova (549_CR11) 2016; 7
A Sgorbissa (549_CR18) 2012; 23
RH Chen (549_CR23) 2020; 11
DE Costea (549_CR8) 2013; 73
CH Lee (549_CR31) 2013; 230
J Li (549_CR34) 2024; 13
MA Dickson (549_CR54) 2000; 20
SV Puram (549_CR36) 2017; 171
X Chen (549_CR3) 2019; 18
YC Yen (549_CR53) 2015; 6
A Calon (549_CR27) 2015; 47
549_CR48
549_CR49
JB Andersen (549_CR19) 2006; 17
G Biffi (549_CR10) 2021; 101
X Yang (549_CR41) 2019; 9
W Zeng (549_CR50) 2023; 42
MG Kellermann (549_CR5) 2007; 51
G Caligiuri (549_CR45) 2023; 41
549_CR52
KJ Bienkowska (549_CR6) 2021; 2
G Lorusso (549_CR2) 2008; 130
Y Fu (549_CR46) 2017; 8
YL Chen (549_CR20) 2019; 38
T Fiaschi (549_CR16) 2012; 72
Y Zou (549_CR47) 2021; 191
S Tang (549_CR15) 2014; 353
T Luo (549_CR38) 2020; 19
E Van Obberghen-Schilling (549_CR33) 1988; 263
References_xml – volume: 8
  start-page: 3984
  year: 2009
  ident: 549_CR17
  publication-title: Cell Cycle
  doi: 10.4161/cc.8.23.10238
– volume: 38
  start-page: 4480
  year: 2019
  ident: 549_CR20
  publication-title: Oncogene
  doi: 10.1038/s41388-019-0731-8
– volume: 38
  start-page: 675
  year: 2020
  ident: 549_CR26
  publication-title: Nat Biotechnol
  doi: 10.1038/s41587-020-0546-8
– volume: 10
  start-page: 12044
  year: 2020
  ident: 549_CR51
  publication-title: Theranostics
  doi: 10.7150/thno.47901
– volume: 7
  year: 2016
  ident: 549_CR11
  publication-title: Nat Commun
  doi: 10.1038/ncomms10305
– ident: 549_CR52
  doi: 10.3390/cancers12010061
– volume: 22
  start-page: 5157
  year: 2002
  ident: 549_CR55
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.22.14.5157-5172.2002
– volume: 73
  start-page: 3888
  year: 2013
  ident: 549_CR8
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-12-4150
– ident: 549_CR35
  doi: 10.3390/cancers13061230
– volume: 171
  start-page: 1611
  year: 2017
  ident: 549_CR36
  publication-title: Cell
  doi: 10.1016/j.cell.2017.10.044
– volume: 41
  start-page: 81
  year: 2022
  ident: 549_CR43
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-022-02300-w
– volume: 478
  start-page: 93
  year: 2020
  ident: 549_CR42
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2020.03.004
– volume: 17
  start-page: 135
  year: 2010
  ident: 549_CR13
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2009.12.041
– volume: 34
  start-page: 1286
  year: 2013
  ident: 549_CR14
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgt035
– volume: 145
  start-page: 2827
  year: 2019
  ident: 549_CR12
  publication-title: Int J Cancer
  doi: 10.1002/ijc.32613
– volume: 23
  start-page: 307
  year: 2012
  ident: 549_CR18
  publication-title: Cytokine Growth Factor Rev
  doi: 10.1016/j.cytogfr.2012.07.003
– volume: 8
  start-page: 57813
  year: 2017
  ident: 549_CR46
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.18175
– volume: 353
  start-page: 133
  year: 2014
  ident: 549_CR15
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2014.07.028
– volume: 146
  start-page: 895
  year: 2020
  ident: 549_CR29
  publication-title: Int J cancer
  doi: 10.1002/ijc.32193
– volume: 7
  start-page: e43593
  year: 2012
  ident: 549_CR57
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0043593
– volume: 2
  year: 2021
  ident: 549_CR6
  publication-title: Front Oral Health
  doi: 10.3389/froh.2021.686337
– volume: 47
  start-page: 320
  year: 2015
  ident: 549_CR27
  publication-title: Nat Genet
  doi: 10.1038/ng.3225
– volume: 41
  start-page: 434
  year: 2023
  ident: 549_CR45
  publication-title: Cancer cell
  doi: 10.1016/j.ccell.2023.02.015
– volume: 68
  start-page: 581
  year: 2017
  ident: 549_CR25
  publication-title: Mol cell
  doi: 10.1016/j.molcel.2017.10.003
– volume: 51
  start-page: 849
  year: 2007
  ident: 549_CR5
  publication-title: Histopathology
  doi: 10.1111/j.1365-2559.2007.02873.x
– volume: 72
  start-page: 5130
  year: 2012
  ident: 549_CR16
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-12-1949
– volume: 41
  start-page: 254
  year: 2022
  ident: 549_CR56
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-022-02456-5
– volume: 20
  year: 2020
  ident: 549_CR37
  publication-title: Cancer Cell Int
  doi: 10.1186/s12935-020-01255-2
– volume: 20
  start-page: 1436
  year: 2000
  ident: 549_CR54
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.20.4.1436-1447.2000
– volume: 14
  start-page: 1205
  year: 2021
  ident: 549_CR40
  publication-title: OncoTargets Ther
  doi: 10.2147/OTT.S294725
– volume: 12
  start-page: R56
  year: 2010
  ident: 549_CR58
  publication-title: Breast Cancer Res
  doi: 10.1186/bcr2615
– volume: 130
  start-page: 1091
  year: 2008
  ident: 549_CR2
  publication-title: Histochem Cell Bio
  doi: 10.1007/s00418-008-0530-8
– ident: 549_CR49
  doi: 10.3390/biology12071002
– volume: 44
  start-page: 646
  year: 2008
  ident: 549_CR9
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2007.08.012
– ident: 549_CR30
  doi: 10.3390/cancers12071718
– volume: 18
  start-page: 99
  year: 2019
  ident: 549_CR3
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/s41573-018-0004-1
– volume: 41
  start-page: 444
  year: 2012
  ident: 549_CR7
  publication-title: J Oral Pathol Med Off Publ Int Assoc Oral Pathologists Am Acad Oral Pathol
– volume: 427
  start-page: 649
  year: 2012
  ident: 549_CR39
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2012.09.115
– volume: 19
  start-page: 153303382097167
  year: 2020
  ident: 549_CR38
  publication-title: Technol Cancer Res Treat
  doi: 10.1177/1533033820971670
– volume: 6
  start-page: 392
  year: 2006
  ident: 549_CR32
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1877
– volume: 9
  start-page: 356
  year: 2019
  ident: 549_CR41
  publication-title: Front Oncol
  doi: 10.3389/fonc.2019.00356
– volume: 230
  start-page: 298
  year: 2013
  ident: 549_CR31
  publication-title: J Pathol
  doi: 10.1002/path.4173
– volume: 50
  year: 2017
  ident: 549_CR28
  publication-title: Biol Res
  doi: 10.1186/s40659-017-0108-9
– ident: 549_CR48
  doi: 10.1172/JCI144888
– volume: 13
  start-page: 63
  year: 2024
  ident: 549_CR34
  publication-title: Exp Hematol Oncol
  doi: 10.1186/s40164-024-00531-5
– volume: 6
  start-page: 7221
  year: 2015
  ident: 549_CR21
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3372
– volume: 16
  start-page: 582
  year: 2016
  ident: 549_CR4
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc.2016.73
– volume: 24
  start-page: 420
  year: 2018
  ident: 549_CR44
  publication-title: Clin Cancer Res Off J Am Assoc Cancer Res
  doi: 10.1158/1078-0432.CCR-17-1776
– volume: 11
  year: 2020
  ident: 549_CR23
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.594775
– volume: 41
  start-page: 374
  year: 2023
  ident: 549_CR1
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2023.02.016
– volume: 101
  start-page: 147
  year: 2021
  ident: 549_CR10
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00048.2019
– volume: 17
  start-page: 411
  year: 2006
  ident: 549_CR19
  publication-title: Cytokine Growth Factor Rev
  doi: 10.1016/j.cytogfr.2006.10.001
– volume: 37
  start-page: 246
  year: 2017
  ident: 549_CR22
  publication-title: J Interferon Cytokine Res
  doi: 10.1089/jir.2016.0103
– volume: 74
  start-page: 7309
  year: 2014
  ident: 549_CR24
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-14-1354
– volume: 191
  start-page: 857
  year: 2021
  ident: 549_CR47
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2021.02.010
– volume: 6
  start-page: 41837
  year: 2015
  ident: 549_CR53
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.5995
– volume: 42
  start-page: 224
  year: 2023
  ident: 549_CR50
  publication-title: Oncogene
  doi: 10.1038/s41388-022-02540-2
– volume: 263
  start-page: 7741
  year: 1988
  ident: 549_CR33
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)68561-8
SSID ssj0000561655
Score 2.3473291
Snippet Cancer-associated fibroblast (CAF) recruitment and activation within the tumor microenvironment (TME) are increasingly acknowledged as drivers of oral squamous...
Abstract Cancer-associated fibroblast (CAF) recruitment and activation within the tumor microenvironment (TME) are increasingly acknowledged as drivers of oral...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 6
SubjectTerms 13/1
13/105
13/21
13/51
38/39
38/90
42/109
631/443/319
631/67/1536
631/67/2327
631/67/327
631/80/84
64/60
Actin
Apoptosis
Cancer
CD11a antigen
Cell Biology
Fibroblast activation protein
Fibroblasts
Gene expression
Glucose metabolism
Glycolysis
Human Genetics
Immunohistochemistry
Internal Medicine
Lactic acid
Leukocyte migration
LFA-1 antigen
Lymphocytes
Medicine
Medicine & Public Health
Metastases
Oncology
Oral cancer
Oral carcinoma
Oral squamous cell carcinoma
Smooth muscle
Squamous cell carcinoma
Tumor microenvironment
Tumors
Vimentin
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZbxMxELagSIgXxM3SgozEG1jd9bHHE4JCKUjlhVbKm-WzjUR20-ymUn9A_zczziZVuF6zVjKZ-Wx_c-wMIW9cVeWOB8ewVQyTtg7MgqPFbKWUdcJ4l8Z0Hn8vj07lt4majAG3fiyrXJ-J6aD2ncMY-T7ccyWwl5oX7-cXDKdGYXZ1HKFxm9zB1mWI6mpSbWIsyI5LpcZ3ZXJR7_cSE3MMZ7giWWkY37qPUtv-v3HNP0smf8ubpuvo8AG5P_JI-mFl-IfkVmgfkbvHY6b8Mbk-Wc66BcW4PPOAssvg6dcfXwpF56kAL_Q0gqfcWWDPA4Vjb7GcpoJzOm0pvrVP-4ulwbhA-g7qcOZQ280MvZwaevCpKAxbD9Ad6NnPKwDUFchCsUtmKvmagdxPyOnh55ODIzaOXGBONnJgtmxiHosyr00FvpRQRaythVs8GmOULUrDS9dIa0LpqyiDqZzg1tbI0XnkVjwlO23XhueEeh58LCP4Qw0s5Llx0dfe5BGwmxuvMvJ2rXg9X3XW0CkjLmq9MpMGM-lkJs0z8hFts1mJXbHTB93iTI-bTJvgiwC_aV0FjpjyxluDiercCe-9kBnZW1tWj1u11zfAysjrzWPYZKhd0wZQdFojJHhXIiPPVkDYSCKx2TOwzozUWxDZEnX7STs9T428wbnDoW-gindrNN3I9W9dvPj_39gl93gCuGBFsUd2hsUyvATmNNhXaXv8ApAcGsA
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature HAS Fully OA
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELaqVkJcEG9CCzISN7CIX4lzXAqlrFQubaXeLD_LSmxSdrOV-gP6vxl7k0UL5cA18W5GM5_tbzzjGYTeurouHQuOpFIxRFgViAVHi9haSuu48S636Tz5Vh2fi-mFvNhBbLwLk5P2c0nLvEyP2WEfliJF1EhqvppYRkNg2d1LpdoB23uTyfR0ujlZSZy4knK4IVNydcePt3ahXKz_Lob5d6LkH9HSvAkdPUQPBvaIJ2t5H6Gd0D5G906G-PgTdHu2mncLnE7jiQdsXQePv55-oRJf5bS7sMQR_OPOAmfuMSx2i9Usp5njWYvTXX28_Lky6TQg_wd2qdNQ280Nvp4ZfPiJUkPGtrk9vvxxAzC6AVlwqo2ZE73mIPdTdH70-ezwmAyNFogTjeiJrZpYRlqVytTgQXFJo7IW9u5ojJGWVoZVrhHWhMrXUQRTO86sVYmZs8gsf4Z2264NLxD2LPhYRfCCGhjISuOiV96UERBbGi8L9G5UvL5a19PQOQ7OlV6bSYOZdDaTZgX6mGyzGZlqYecH3eJSD9jQJnga4JvW1eB-SW-8NSk8XTruveeiQAejZfUwQZcaaFMFZFgxWqA3m9cwtZJ2TRtA0XkMF-BT8QI9XwNhI4lIJZ6BaxZIbUFkS9TtN-3sey7fDS5davUGqng_oum3XP_Wxcv_G76P7rMMeE4oPUC7_WIVXgF_6u3rYcL8AtpRGfE
  priority: 102
  providerName: Springer Nature
Title Tumor cell-derived ISG15 promotes fibroblast recruitment in oral squamous cell carcinoma via CD11a-dependent glycolytic reprogramming
URI https://link.springer.com/article/10.1038/s41389-025-00549-2
https://www.ncbi.nlm.nih.gov/pubmed/40069143
https://www.proquest.com/docview/3176115821
https://www.proquest.com/docview/3176343063
https://pubmed.ncbi.nlm.nih.gov/PMC11897235
https://doaj.org/article/aed1ef6fbc75485dadba03630c3ddd34
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFLZgSIgXxJ3AqIzEG1iL7dhJHruyMSptQmyT-mb5OirRdLTppP0A_jfHTlpWLuKFp0qJVR2d8zn-Ts7JdxB6Y8syt8xbEqViSGEqTwwkWsSUQhjLtbNpTOfxiTw6L8YTMbkx6iv2hHXywJ3j9rR31AcZjC2BXAunndGx-Jhb7pzjSQkUzrwbyVSn6i2pFKL_Sibn1d6yiCU5Eqe3RppSE7Z1EiXB_j-xzN-bJX-pmKaD6PABut8zSDzsLH-IbvnmEbp73NfIH6PvZ6vZfIHjG3niAF9X3uGPpx-owJep9c4vcYAceW6AN7cYHniL1TS1muNpg-P3-nj5baXjG4H0H9jGaUPNfKbx1VTj0XtKNVmPzm3xxddrgNI12IKjPmZq9pqB3U_Q-eHB2eiI9MMWiC3qoiVG1iEPVOaVLiGL4oKGyhg4v4PWWhgqNZO2Loz20pWh8Lq0nBlTRXbOAjP8Kdpp5o1_jrBj3kHEIBOqYSHLtQ2ucjoPgNpcO5Ght2vHq8tOU0OlWjivVBcmBWFSKUyKZWg_xmazMuphpwuAEtWjRP0LJRnaXUdW9Zt0qYA6SSDEFaMZer25Ddsrelc3Hhyd1vAC8iqeoWcdEDaWFFHmGfhmhqotiGyZun2nmX5JEt6Q1sVxb-CKd2s0_bTr77548T988RLdY2kbcELpLtppFyv_CphVawbodjkpB-jOcDg-HcPv_sHJp89wdSRHg7TBfgAXIioS
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIgEXxBtDgUWCE6xq7_qVA0LQUhLa9EIq5bbss0QidppHUX4Af4ffyMzGThVet17tlT2ex843O-MZQl6YoogNd4ZhqxiW6tIxDYEW00WWaSOUNWFMZ_84756kn4bZcIv8bP-FwbLKdk8MG7WtDZ6R74KfywG9lDx5OzljODUKs6vtCI2VWhy65XcI2WZvevsg35ecH3wY7HVZM1WAmbSTzpnOOz72SR6XqoBwQWSJL7UGR-WVUplOcsVz00m1crktfOpUYQTXukQYyj3XAp57hVwFxxtjsFcMi_WZDqLxPMuaf3NiUe7OUkwEMpwZi-Cow_iG_wtjAv6Gbf8s0fwtTxvc38EtcrPBrfTdStFuky1X3SHX-k1m_i75MViM6ynFPACzoNXnztLe549JRieh4M_NqIfIvNaA1ucUttnpYhQK3OmootglgM7OFgrPIcIzqMEZR1U9VvR8pOjefpIo1g7sndPTb0tQ4CXQQrErZygxGwPd98jJpQjjPtmu6so9JNRyZ33uIf7qwEIeK-NtaVXswVZiZbOIvGoZLyerTh4yZOBFKVdikiAmGcQkeUTeo2zWK7ELd7hQT09lY9RSOZs4eKc2BQR-mVVWK0yMx0ZYa0UakZ1WsrLZGmbyQpEj8nx9G4wauasqB4wOa0QK0ZyIyIOVIqwpSbG5NKDciJQbKrJB6uadavQ1NA6HYBKHzAErXrfadEHXv3nx6P-f8Yxc7w76R_Kod3z4mNzgQdkFS5Idsj2fLtwTQG1z_TSYCiVfLts2fwH3-1gp
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ZbxMxELZKKlW8IG4WChgJnsDKrr1XHhCiTUNDaVRBK_Vt67NEIrtpjqL8AP4Uv44ZZzdVuN76umt5Z-ew5_OMZwh5qbMs1NxqhqViWKxyyxQALaayJFFaSKN9m87DQbp_En88TU43yM_mLgymVTZrol-oTaXxjLwN-1wK3kvOo7ar0yKOur134wuGHaQw0tq001iqyIFdfAf4Nn3b74KsX3He2zve3Wd1hwGm4048YyrtuNBFaZjLDKCDSCKXKwWblpNSJipKJU91J1bSpiZzsZWZFlypHF1S7rgSMO8NspkhKmqRzZ29wdHn1QkP-uZpktQ3dUKRt6cxhgUZdpBFV6nD-Npu6JsG_M3T_TNh87eord8Me7fJrdqLpe-XaneHbNjyLtk6rOP098iP4_momlCMCjADOn5pDe1_-RAldOzT_-yUOsDplQLffUZh0Z3Mhz7dnQ5LijUD6PRiLvFUws9BNXY8KquRpJdDSXe7USRZ0753Rs-_LUCdF0ALxRqdPuFsBHTfJyfXIo4HpFVWpX1EqOHWuNQBGuvAQB5K7UxuZOjAckJpkoC8bhhfjJd1PQofjxd5sRRTAWIqvJgKHpAdlM1qJNbk9g-qyXlRm3ghrYksfFPpDGBgYqRREsPkoRbGGBEHZLuRbFEvFNPiSq0D8mL1GkwcuStLC4z2Y0QM2E4E5OFSEVaUxFhqGnzegORrKrJG6vqbcvjVlxEHaIkt54AVbxptuqLr37x4_P_feE62wC6LT_3BwRNyk3tdFyyKtklrNpnbp-DCzdSz2lYoObtu8_wFqhFdxA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tumor+cell-derived+ISG15+promotes+fibroblast+recruitment+in+oral+squamous+cell+carcinoma+via+CD11a-dependent+glycolytic+reprogramming&rft.jtitle=Oncogenesis+%28New+York%2C+NY%29&rft.au=Wang%2C+Ssu-Han&rft.au=Chen%2C+Yu-Lin&rft.au=Huang%2C+Shih-Han&rft.au=Fu%2C+Yu-Ke&rft.date=2025-03-11&rft.issn=2157-9024&rft.eissn=2157-9024&rft.volume=14&rft.issue=1&rft.spage=6&rft_id=info:doi/10.1038%2Fs41389-025-00549-2&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2157-9024&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2157-9024&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2157-9024&client=summon